Loading companies…
Loading companies…
United States · Biotech · Healthtech · Enterprise software
Platform that discovers and de-risks novel drug programs in ophthalmology and cardiology via affiliate company model
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series B | $190M | Horowitz Group — Role not disclosedInvus Opportunities — Role not disclosedPatient Square Capital — Role not disclosedRetinal Degeneration Fund — Role not disclosed |